WHICH POLYMERS CAN MAKE NANOPARTICULATE DRUG CARRIERS LONG-CIRCULATING

被引:366
作者
TORCHILIN, VP [1 ]
TRUBETSKOY, VS [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02129
关键词
LONG-CIRCULATING DRUG CARRIERS; LIPOSOMES; NANOPARTICLES; POLY(ETHYLENE GLYCOL); AMPHIPHILIC FLEXIBLE POLYMERS; POLYMER CONFORMATIONS;
D O I
10.1016/0169-409X(95)00022-Y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protective effect of poly(ethylene glycol) and some other polymers on nanoparticulate carriers including liposomes is considered in terms of statistical behavior of macromolecules in solution, when polymer flexibility plays a key role. According to the mechanism proposed, surface-grafted chains of flexible and hydrophilic polymers form dense ''conformational clouds'' preventing other macromolecules from the interaction with the surface even at low concentration of protecting polymer. Using liposomes as an example, experimental evidence is presented of the importance of protecting polymer flexibility in liposome steric protection. Further possible applications of the suggested model are discussed. The possibility of using protecting polymers other than poly(ethylene glycol) is analyzed, and examples of such polymers are given based on polymer-coated liposome biodistribution data. General requirements for protecting polymers are formulated, and differences in steric protection of liposomes and particles are discussed. The scale of protective effect is interpreted as the balance between the energy of hydrophobic anchor interaction with the liposome membrane core or with the particle surface and the energy of polymer chain free motion in solution.
引用
收藏
页码:141 / 155
页数:15
相关论文
共 54 条
[1]  
Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
[2]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[3]   THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
ALLEN, TM .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) :285-309
[4]  
[Anonymous], 1988, LIPOSOMES DRUG CARRI
[5]   SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES [J].
BLUME, G ;
CEVC, G ;
CROMMELIN, MDJA ;
BAKKERWOUDENBERG, IAJM ;
KLUFT, C ;
STORM, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (01) :180-184
[6]   MOLECULAR MECHANISM OF THE LIPID VESICLE LONGEVITY INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1146 (02) :157-168
[7]  
BLUNK T, 1993, 20TH P INT S CONTR R, P256
[8]   SEPARATION OF LARGE UNILAMELLAR LIPOSOMES FROM BLOOD COMPONENTS BY A SPIN COLUMN PROCEDURE - TOWARDS IDENTIFYING PLASMA-PROTEINS WHICH MEDIATE LIPOSOME CLEARANCE INVIVO [J].
CHONN, A ;
SEMPLE, SC ;
CULLIS, PR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1070 (01) :215-222
[9]  
CHONN A, 1992, J BIOL CHEM, V267, P18759
[10]  
Des Cloizeaux J, 1990, POLYM SOLUTION THEIR